Immediate Impact
19 standout
Citing Papers
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Recent advances in targeted strategies for triple-negative breast cancer
2023 Standout
Works of Roger Blum being referenced
Preclinical Rationale and Phase I Clinical Trial of the Adriamycin Analog, AD 32
1981
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Roger Blum | 18 | 10 | 7 | 64 | 49 | 17 | 147 | |
| Jia Tan | 20 | 35 | 44 | 10 | 18 | 193 | ||
| Shwetha V. Kumar | 1 | 7 | 43 | 21 | 187 | |||
| Vamshi Muddu | 2 | 12 | 9 | 19 | 229 | |||
| Kyle T. Bradley | 2 | 8 | 13 | 16 | 122 | |||
| Marvin A. Lewis | 19 | 2 | 22 | 19 | 157 | |||
| Pascal Jonker | 2 | 28 | 3 | 13 | 175 | |||
| Tatiana Nayara Libório‐Kimura | 1 | 2 | 2 | 3 | 20 | 27 | 176 | |
| Li Lin | 2 | 9 | 66 | 6 | 18 | 247 | ||
| Supreet Kaur | 5 | 3 | 29 | 19 | 130 | |||
| Charlotte A.H. Lange | 60 | 3 | 15 | 205 |
All Works
Loading papers...